Antimicrobial Susceptibility Patterns and Genetic Determinants of Carbapenem and Aminoglycoside Resistance Among Serratia marcescens Bloodstream Isolates

Objective: Serratia marcescens (S. marcescens) is an important opportunistic pathogen associated with bloodstream infections, particularly in intensive care units (ICUs). This study aimed to evaluate antimicrobial susceptibility patterns and to investigate genetic determinants associated with carbapenem and aminoglycoside resistance among S. marcescens bloodstream isolates.Methods: A total of 98 non-duplicate S. marcescens isolates recovered from blood cultures between 2019 and 2023 were retrospectively analyzed. Species identification was performed using MALDI-TOF MS. Antimicrobial susceptibility testing was carried out by disk diffusion and interpreted according to EUCAST version 14.0 criteria. Phenotypic assays were used to detect carbapenemase activity. Carbapenem-resistant isolates were screened by polymerase chain reaction for blaKPC, blaNDM, blaOXA-48, blaVIM, blaIMP, and the 16S rRNA methyltransferase gene rmtB.Results: Adult patients accounted for 75.5% of the isolates, and approximately 40% originated from ICUs across all age groups. High susceptibility rates were observed for third- and fourth-generation cephalosporins, carbapenems, aminoglycosides, fluoroquinolones, and trimethoprim–sulfamethoxazole, whereas resistance rates to amoxicillin–clavulanate (96.9%) and cefoxitin (54.1%) were high, reflecting intrinsic resistance mechanisms. Carbapenem resistance was detected in three isolates (3.1%), two of which exhibited phenotypic carbapenemase activity. Polymerase chain reaction analysis revealed blaNDM in one isolate and blaVIM in another, whereas rmtB was not detected.Conclusion: Although the overall antimicrobial susceptibility profile of S. marcescens bloodstream isolates remains favorable, the emergence of NDM- and VIM-producing S. marcescens strains highlights the necessity for continuous local surveillance and strict infection-control practices, particularly in ICUs.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Health Sciences
Published
2026-03-27
DOI
https://doi.org/10.33808/clinexphealthsci.1861350
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antimicrobial Susceptibility Patterns and Genetic Determinants of Carbapenem and Aminoglycoside Resistance Among Serratia marcescens Bloodstream Isolates

Nurver Toprak Ülger, Damla Ataç, Arzu Akşit İlki, Ufuk Hasdemir et al.
Clinical and Experimental Health Sciences
Antibiotic Resistance in Bacteria
article

Antimicrobial Susceptibility Patterns and Genetic Determinants of Carbapenem and Aminoglycoside Resistance Among Serratia marcescens Bloodstream Isolates

Nurver Toprak Ülger, Damla Ataç, Arzu Akşit İlki, Ufuk Hasdemir, Elvan Sayin, Barış Can
article en

Abstract

Objective: Serratia marcescens (S. marcescens) is an important opportunistic pathogen associated with bloodstream infections, particularly in intensive care units (ICUs). This study aimed to evaluate antimicrobial susceptibility patterns and to investigate genetic determinants associated with carbapenem and aminoglycoside resistance among S. marcescens bloodstream isolates.Methods: A total of 98 non-duplicate S. marcescens isolates recovered from blood cultures between 2019 and 2023 were retrospectively analyzed. Species identification was performed using MALDI-TOF MS. Antimicrobial susceptibility testing was carried out by disk diffusion and interpreted according to EUCAST version 14.0 criteria. Phenotypic assays were used to detect carbapenemase activity. Carbapenem-resistant isolates were screened by polymerase chain reaction for blaKPC, blaNDM, blaOXA-48, blaVIM, blaIMP, and the 16S rRNA methyltransferase gene rmtB.Results: Adult patients accounted for 75.5% of the isolates, and approximately 40% originated from ICUs across all age groups. High susceptibility rates were observed for third- and fourth-generation cephalosporins, carbapenems, aminoglycosides, fluoroquinolones, and trimethoprim–sulfamethoxazole, whereas resistance rates to amoxicillin–clavulanate (96.9%) and cefoxitin (54.1%) were high, reflecting intrinsic resistance mechanisms. Carbapenem resistance was detected in three isolates (3.1%), two of which exhibited phenotypic carbapenemase activity. Polymerase chain reaction analysis revealed blaNDM in one isolate and blaVIM in another, whereas rmtB was not detected.Conclusion: Although the overall antimicrobial susceptibility profile of S. marcescens bloodstream isolates remains favorable, the emergence of NDM- and VIM-producing S. marcescens strains highlights the necessity for continuous local surveillance and strict infection-control practices, particularly in ICUs.

Clinical and Experimental Health SciencesVol. 16(1)
Marmara University (TR)
Life in Land
Openalex Percentile: Top 6%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antimicrobial Susceptibility Patterns and Genetic Determinants of Carbapenem and Aminoglycoside Resistance Among Serratia marcescens Bloodstream Isolates — Nurver Toprak Ülger, Damla Ataç, et al. · Clinical and Experimental Health Sciences (2026) | TGRS Research Map | TGRS